Evommune, the decline stays in control
Evommune slides 6.4% as the decline keeps making lower lows
Evommune, the decline stays in control
Our view last week
Evommune shares slide 8.1% this week, but the daily chart tells a different story: the stock carved a clean double bottom in the 12 area, with a 23% intermediate rebound off the lows. The sell signal is in its third week and the confirmation week closed bearish: discipline calls for holding the position unchanged. Money flow stays deep in distribution and volatility is elevated — a technical picture still jumpy, not one to chase right now.
This week's summary
Evommune shares slide another 6.4% this week, the fourth straight lower high from the 14 area down to the 12 area: the sequence confirms the decline is still intact. Signal strength reads "downtrend making lower lows, pace holding" — a healthy decline with no sign of exhaustion — while the short is already more than 12% in profit. In this technical analysis, volatility stands out too, running very high: the quality band flags trading as not recommended for fresh entries.
IQS Phase
81
in tension / maturity
Signal Strength
46
downtrend making lower lows, pace holding
Sizing
REDUCED
Ranking
#44 / 141
US stocks sell signals
Trade P&L %
+12.35%
from signal to today
Rank position
ranks 44th among the 141 sell signals for US stocks in our ranking, with a signal strength of 46 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
EVMN belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content